1. NF-κB
  2. NF-κB

Ceruletide (Synonyms: Caerulein; Cerulein)

Cat. No.: HY-A0190 Purity: 99.96%
Handling Instructions

Ceruletide, a biologically active decapeptide isolated from the skin of the Australian frog Hyla caerulea, is a potent cholecystokinetic agent; also activates NF-kappaB/Rel in vitro.

For research use only. We do not sell to patients.

Custom Peptide Synthesis

Ceruletide Chemical Structure

Ceruletide Chemical Structure

CAS No. : 17650-98-5

Size Price Stock Quantity
10 mM * 1 mL in Water USD 1071 In-stock
Stock in Sweden
Estimated Time of Arrival: December 31
1 mg USD 108 In-stock
Stock in Sweden
Estimated Time of Arrival: December 31
5 mg USD 396 In-stock
Stock in Sweden
Estimated Time of Arrival: December 31
10 mg USD 720 In-stock
Stock in Sweden
Estimated Time of Arrival: December 31
50 mg   Get quote  
100 mg   Get quote  

* Please select Quantity before adding items.

Customer Review

    Ceruletide purchased from MCE. Usage Cited in: Am J Transl Res. 2018;10(2):402-410

    Cerulein exposure increases the protein expression of MD2, while ALR reduces the Cerulein-induced upregulation in MD2 protein expression.

    View All NF-κB Isoform Specific Products:

    • Biological Activity

    • Protocol

    • Technical Information

    • Purity & Documentation

    • References

    Description

    Ceruletide, a biologically active decapeptide isolated from the skin of the Australian frog Hyla caerulea, is a potent cholecystokinetic agent; also activates NF-kappaB/Rel in vitro.

    IC50 & Target[2]

    NF-kappaB/Rel

     

    In Vitro

    Ceruletide is similar chemically and biologically to the human gastrointestinal hormones cholecystokinin-pancreozymin (CCK) and gastrin II. Ceruletide stimulates gallbladder contraction, pancreatic exocrine secretion, gastric secretion, and motility in the distal duodenum, jejunum, ileum and colon, while delaying gastric emptying and inhibiting motility in the proximal duodenum[1]. Ceruletide in supramaximal but not in physiological doses activates NF-kappaB/Rel in vitro. This activation may induce a self-defending genetic program before the onset of cellular injury, which may prevent higher degrees of damage of pancreatic acinar cells after secretagogue hyperstimulation[2].

    In Vivo

    Ceruletide (0.4-0.5 mcg/kg, i.v.; 3-4 mcg/kg, s.c.) results in emesis and evacuation of the bowel in the intact conscious dog, and recovery is complete 15-30 min after i. v. administration and 2-4 hr after s.c. administration. Ceruletide (5-15 ng/kg, i.v.) shows a marked spasmogenic effect on the pylorus of rats. Ceruletide also reduces blood pressure in anesthetized dogs[1]. Ceruletide serum bile acid (SBA) stimulation circumvents exogenous and endogenous influences associated with postprandial (PP) SBA stimulation. Ceruletide SBA stimulation may perform as well as PP SBA stimulation in dogs with portosystemic shunt (PSS) and be more sensitive for the detection of hepatic dysfunction in dogs with upper respiratory disease (URD)[3].

    References
    Preparing Stock Solutions
    Concentration Volume Mass 1 mg 5 mg 10 mg
    1 mM 0.7394 mL 3.6971 mL 7.3942 mL
    5 mM 0.1479 mL 0.7394 mL 1.4788 mL
    10 mM 0.0739 mL 0.3697 mL 0.7394 mL
    Please refer to the solubility information to select the appropriate solvent.
    Animal Administration
    [3]

    Ceruletide is prepared in food[3].

    Dogs[3]
    All dogs undergo serum bile acid (SBA) stimulation with food (<5 kg/body weight [BW] 2 teaspoons, >5 kg BW 2 tablespoons) or 0.3 μg/kg BW Ceruletide IM, respectively, on consecutive days. A diet of moderate protein content and with an increased concentration of fiber is chosen to minimize metabolic complications such as hepatic encephalopathy. Before each test, the dogs are fasted for 12 hours. Blood samples are drawn at baseline, 60 and 120 minutes after feeding, and 20, 30, and 40 minutes postinjection, respectively. The blood samples are collected in plain tubes and left to clot; they are then centrifuged at 6,500 ×g for 1 minute, and the serum is used to measure SBA by a colorimetric test with endpoint determination[3].
    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References
    Molecular Weight

    1352.41

    Formula

    C₅₈H₇₃N₁₃O₂₁S₂

    CAS No.

    17650-98-5

    SMILES

    O=C(N[[email protected]@H](CCSC)C(N[[email protected]@H](CC(O)=O)C(N[[email protected]](C(N)=O)CC1=CC=CC=C1)=O)=O)[[email protected]@H](NC(CNC([[email protected]@]([[email protected]](O)C)([H])NC([[email protected]@H](NC([[email protected]](CC(O)=O)NC([[email protected]](CCC(N)=O)NC([[email protected]](CC2)NC2=O)=O)=O)=O)CC3=CC=C(OS(=O)(O)=O)C=C3)=O)=O)=O)CC4=CNC5=C4C=CC=C5

    Storage
    Powder -80°C 2 years
      -20°C 1 year
    In solvent -80°C 6 months
      -20°C 1 month
    Shipping

    Room temperature in continental US; may vary elsewhere

    Solvent & Solubility

    H2O: ≥ 100 mg/mL

    * "<1 mg/mL" means slightly soluble or insoluble. "≥" means soluble, but saturation unknown.

    Purity: 99.96%

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product name

     

    Salutation

    Applicant name *

     

    Email address *

    Phone number *

     

    Organization name *

    Country or Region *

     

    Requested quantity *

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Ceruletide
    Cat. No.:
    HY-A0190
    Quantity: